BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin EM, Gong J, Klempner SJ, Chao J. Advances in immuno-oncology biomarkers for gastroesophageal cancer: Programmed death ligand 1, microsatellite instability, and beyond. World J Gastroenterol 2018; 24(25): 2686-2697 [PMID: 29991874 DOI: 10.3748/wjg.v24.i25.2686]
URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2686.htm
Number Citing Articles
Ran Duan, Xiaoqin Li, Dongqiang Zeng, Xiaofeng Chen, Bo Shen, Dongqin Zhu, Liuqing Zhu, Yangyang Yu, Deqiang Wang. Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric CancerFrontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.609337
Yue Song, Zhaoming Li, Weili Xue, Mingzhi Zhang. Predictive Biomarkers for PD-1 and PD-L1 Immune Checkpoint Blockade TherapyImmunotherapy 2019; 11(6): 515 doi: 10.2217/imt-2018-0173
Padmaraju Vasudevaraju, Malla Rama Rao. Immunotherapy for Gastrointestinal MalignanciesDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 79 doi: 10.1007/978-981-15-6487-1_6
Koosha Paydary, Natalie Reizine, Daniel V. T. Catenacci. Immune-Checkpoint Inhibition in the Treatment of Gastro-Esophageal Cancer: A Closer Look at the Emerging EvidenceCancers 2021; 13(23): 5929 doi: 10.3390/cancers13235929
Hans Juergen Grote, Zheng Feng, Michael Schlichting, Christoph Helwig, Mary Ruisi, Hulin Jin, Juergen Scheuenpflug, Claudia-Nanette Gann, Zhen Su, Martin Reck, Everett E. Vokes, Keith M. Kerr. Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 AssayJournal of Thoracic Oncology 2020; 15(8): 1306 doi: 10.1016/j.jtho.2020.04.013
Jianpeng Gao, Shiying Huo, Yu Zhang, Zhenxiong Zhao, Hongda Pan, Xiaowen Liu. Construction of ovarian metastasis‐related immune signature predicting prognosis of gastric cancer patientsCancer Medicine 2023; 12(1): 913 doi: 10.1002/cam4.4857
Gabriela Negrete-Tobar, Alejandro González-Motta, Oscar Alberto Messa-Botero, Juan Carlos Galvis, Isabella Garciandía Rozo, Juan Sebastián Álvarez Martínez, Juliana Pineda Ortega, Natalia Londoño de Vivero, Ricardo Bruges Maya. Inestabilidad microsatelital y cáncer gástricoRevista Colombiana de Cirugía 2021; 36(1): 120 doi: 10.30944/20117582.658
Negar Khoshghamat, Niloufar Jafari, Mehrdad Moetamani-Ahmadi, Ghazaleh Khalili-Tanha, Mohammad-Hossein Khajavi rad, Saeed Sahebdel, Nima Khalili-Tanha, Saman Soleimanpour, Majid Khazaei, Seyed Mahdi Hassanian, Gordon A. Ferns, Amir Avan. Programmed cell death 1 as prognostic marker and therapeutic target in upper gastrointestinal cancersPathology - Research and Practice 2021; 220: 153390 doi: 10.1016/j.prp.2021.153390
Pierre Allemann, Pierre Fournier. Reflux Disease and Adenocarcinoma of the Esophagus and Cardia: Global Management and Surgical TreatmentJournal of Laparoendoscopic & Advanced Surgical Techniques 2020; 30(8): 869 doi: 10.1089/lap.2020.0079
Juliana Knief, Pamela Lazar-Karsten, Richard Hummel, Ulrich Wellner, Christoph Thorns. PD-L1 expression in carcinoma of the esophagogastric junction is positively correlated with T-cell infiltration and overall survivalPathology - Research and Practice 2019; 215(6): 152402 doi: 10.1016/j.prp.2019.03.030
Jie Shi, Xu Yang, Xinmei Wang, Yufeng Luo, Weixun Zhou, Hanhuan Luo, Zhaxi Bianba, Zhuoma Nima, Qian Wang, Han Wang, Ruiqian Liao, Quzhen Ciren, Mei Li, Junyi Pang, Paulo Henrique Braz-Silva. Prevalence of Epstein–Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric CancerBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2684065
Yuting Pan, Yue Ma, Guanghai Dai. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with ImmunotherapyNutrients 2023; 15(19): 4290 doi: 10.3390/nu15194290
Adilai Aisa, Shanshan Weng, Xinyu Li, Ding Zhang, Ying Yuan. Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancerCritical Reviews in Oncology/Hematology 2022; 180: 103864 doi: 10.1016/j.critrevonc.2022.103864
Xiaoyang Duan, Huazhen Du, Ran Qi, Meng Yuan, Jian Shi. The efficacy and safety of first‑line anti‑PD‑1/PD‑L1 immunotherapy for gastric esophageal cancer: A systematic review and meta‑analysis of phase III randomized controlled trialsExperimental and Therapeutic Medicine 2023; 25(5) doi: 10.3892/etm.2023.11915
R. Sundar, K.K. Huang, A. Qamra, K.-M. Kim, S.T. Kim, W.K. Kang, A.L.K. Tan, J. Lee, P. Tan. Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancerAnnals of Oncology 2019; 30(3): 424 doi: 10.1093/annonc/mdy550
Michele Ghidini, Angelica Petrillo, Andrea Botticelli, Dario Trapani, Alessandro Parisi, Anna La Salvia, Elham Sajjadi, Roberto Piciotti, Nicola Fusco, Shelize Khakoo. How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based ApproachesJournal of Clinical Medicine 2021; 10(7): 1412 doi: 10.3390/jcm10071412
Jia-Bin Wang, Ping Li, Xiao-Long Liu, Qiao-Ling Zheng, Yu-Bin Ma, Ya-Jun Zhao, Jian-Wei Xie, Jian-Xian Lin, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Li-Chao Liu, Ning-Zi Lian, Ying-Hong Yang, Chang-Ming Huang, Chao-Hui Zheng. An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancerNature Communications 2020; 11(1) doi: 10.1038/s41467-020-20260-7
Gianluca Lopez, Konstantinos Venetis, Elham Sajjadi, Nicola Fusco. Mismatch Repair System Genomic Scars in Gastroesophageal Cancers: Biology and Clinical TestingGastrointestinal Disorders 2020; 2(4): 341 doi: 10.3390/gidisord2040031